Clinical Research Directory
Browse clinical research sites, groups, and studies.
Evaluating the Impact of Centralized Interventions on Lung Cancer Screening Adherence in Community Settings, ACCELL Trial
Sponsor: Fred Hutchinson Cancer Center
Summary
This clinical trial tests the impact of lung cancer screening care coordination interventions implemented at the system-level on lung cancer screening adherence in community settings. Lung cancer remains the leading cause of cancer death in the United States. Although lung cancer screening (LCS) with yearly low-dose chest computed tomography has the potential to decrease lung deaths, the use of this screening technique remains low. In addition, studies have shown that adherence to lung cancer screening in clinical settings is far lower that those found in clinical trials. Improved care coordination services that include comprehensive, system-wide tracking of screening outcomes for all LCS participants, results reporting with direct-to-patient information, direct patient and physician communication, and active reviews of non-adherent patients and stepped support interventions may increase patient adherence to LCS. Coordination services at the system-level may decrease barriers and improve adherence to lung cancer screening in community settings.
Official title: Evaluating Centralizing Interventions to Address Low Adherence to Lung Cancer Screening Follow-Up in Decentralized Settings (The ACCELL Interventional Trial)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
6772
Start Date
2025-03-01
Completion Date
2027-09-30
Last Updated
2025-11-20
Healthy Volunteers
Yes
Conditions
Interventions
Electronic Health Record Review
Ancillary studies
Interview
Ancillary studies
Patient Navigation
Receive lung cancer screening care coordination services
Locations (1)
Fred Hutch/University of Washington Cancer Consortium
Seattle, Washington, United States